Medicinal Cannabis Research and Development

Cannasouth is a science-led company with ongoing research programmes targeted at developing next-generation medicinal cannabis products.

Medicinal cannabis research is at the heart of what we do and is a core value in our companies vision. We have extensive research programmes making Cannasouth leaders of the NZ medicinal cannabis industry.

Developing a deeper understanding of the interaction of phytocannabinoids with the endocannabinoid system will lead to improved quality of life, and better outcomes for patients.

PhD Cannabinoid study focussing on purification.

This PhD study covers the science of extraction, fractionation, purification and degradation dynamics of specific phytocannabinoid compounds and chemicals found naturally in medicinal cannabis.

Involving the use of leading-edge purification technology able to separate all the major as well as the minor cannabinoids to upwards of 99%+ purity.

Masters – Tissue Culture & Medicinal Cannabis.

In-vitro tissue culture (micropropagation) of cannabis offers a number of potential advantages over the more widely used cutting-based method for producing clonal cannabis plants.

Tissue culture enables superior genetic stability, cultivar storage enhancement and aseptic culture that is free of pests and disease.

PhD Study – Cannabinoids & Neuropathic pain.

This PhD programme will be focused on neuropathic pain and cannabinoid compound efficacy validation.

With the aim to assess the efficacy of discrete bioactive compounds extracted from cannabis in pre-clinical models of neuropathic pain in order to define optimal formulations, dosage and relevant clinical indications.

Masters – CBD Purification

This Masters study involved raw cannabis compounds purified via analytical and preparative HPLC systems.

Fractions were screened by 1H NMR spectroscopy and analysed by GC mass spectrometry resulting in the production of high purity 99%+ compounds of CBD, CBDA, THC & THCA produced from Cannasouth’s New Zealand growing trials.

To create the highest quality medicinal cannabis compounds and medicines we start with the healthiest natural plants available.

We then extract and refine them with care, skill and attention to detail to retain the delicate cannabinoid compounds, flavonoids, and terpenes.

Finally, we will be carefully formulating and manufacturing these compounds into a broad range of innovative therapeutic cannabinoid-based solutions for clinicians, doctors, and patients.

Cannasouth cultivation facility

Cannasouth cultivates high quality cannabis flower for our R&D programmes. Our high-tech greenhouses will harness the power of the sun to produce some of New Zealand’s finest medical cannabis.

We believe in sustainability, incorporating systems that will harness the benefits of natural rainwater, heating, cooling and conservation.

Pure cannabinoid extracts

The extraction of pure cannabis oil requires world-class technology. Cannasouth’s laboratory facilities ensure all our products meet the highest standards of quality assurance.

Cannasouth will be using GMP  standards throughout extraction and formulation to create best in class products for doctors, clinicians and patients

Sameek Singh

Cannasouth will be formulating its product ranges to the highest standards to create innovative cannabinoid medicines able to support patient health outcomes.

Offering therapeutic solutions and formulations, tailored to specific needs and medical conditions for a broad range of health problems and illness conditions requiring treatment.